万家中证港股通创新药ETF发起式联接C(023482)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
8,257,078.71 |
15,502,417.47 |
8,260,336.45 |
| 存出保证金 |
- |
- |
- |
| 交易性金融资产 |
176,144,120.46 |
291,305,470.61 |
143,541,067.74 |
| 其中：股票投资 |
- |
- |
- |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
4,078,833.46 |
5,335,754.46 |
9,161,115.62 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
194,841,158.06 |
327,995,657.97 |
171,050,014.61 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
| 应付赎回款 |
8,760,414.27 |
19,517,997.52 |
18,778,939.76 |
| 应付管理人报酬 |
4,799.57 |
7,682.96 |
3,482.77 |
| 应付托管费 |
959.91 |
1,536.58 |
696.55 |
| 应付销售服务费 |
32,214.14 |
48,570.13 |
15,144.62 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
7,346.28 |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
147,651.16 |
90,701.44 |
2,436.17 |
| 负债合计 |
8,946,039.05 |
19,666,488.63 |
18,808,046.15 |
| 所有者权益 |
| 实收基金 |
160,492,325.32 |
237,042,286.52 |
123,298,296.17 |
| 未分配利润 |
25,402,793.69 |
71,286,882.82 |
28,943,672.29 |
| 所有者权益合计 |
185,895,119.01 |
308,329,169.34 |
152,241,968.46 |
| 负债及所有者权益总计 |
194,841,158.06 |
327,995,657.97 |
171,050,014.61 |
微信公众号
证券之星APP
基本资料
